Results from a collaborative study highlight who is most at risk of developing complications from COVID-19.

BRI President Jane Buckner shares an update on BRI's work and introduces the new brand.

Uma Malhotra, MD, explains how to safely move into the next phases of the pandemic.

Carmen Mikacenic, MD, is using her perspective as a clinician and knowledge of a severe inflammatory syndrome to examine how COVID-19 affects the lungs.

An expert on infectious diseases like COVID-19 shares her recommendations for credible information resources on the pandemic.

A resilient family shares how how they've adapted to autoimmune disease, and what gives them hope.

In collaboration with Virginia Mason, BRI researchers are studying COVID-19 patient blood samples to decode the immune response.

Dr. Astrid Pujari offers tips on how people with autoimmune disease can relieve stress.

Zoey Brooke's in-person study visits may have been canceled due to the pandemic, but she isn’t giving up.

Only about half of IBD patients respond to today’s drugs — and only about 20 percent achieve remission. BRI researchers are working to change that.